Adaptimmune Therapeutics shares owned by Redmile Group
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Redmile Group
from 13F filings
Historical chart of Redmile Group investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Redmile Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Redmile Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $698k | 716k | 0.97 |
| 2024-03-31 | $1.1M | 716k | 1.58 |
| 2023-12-31 | $568k | 716k | 0.79 |
| 2023-09-30 | $558k | 716k | 0.78 |
| 2023-06-30 | $662k | 716k | 0.93 |